GENEVA, June 19 -- GUANGDONG JIANERSHENG PHARMACEUTICAL TECHNOLOGY CO., LTD. filed a patent application (CN2026/070705) for “USE OF DITHIOCARBAMATE COMPOUNDS IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING OSTEOPOROSIS”. With publication no. WO/2026/103962, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 31/198
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....